Newly Identified Brain Cancer Mutation Hopes To Aid Drug Development

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists     Duke University investigators have recently published and esoteric molecular genetics research finding that may increase our ability to understand the biology of pediatric intrinsic brainstem gliomas.  http://corporate.dukemedicine.org/news_and_publications/news_office/news/newly-identified-brain-cancer-mutation-will-aid-drug-development?utm_source=corporate.dukemedicine.org&utm_medium=rss&utm_campaign=RSS_news These are devastating […]